Wojciech Rogowski

3.7k total citations
40 papers, 650 citations indexed

About

Wojciech Rogowski is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wojciech Rogowski has authored 40 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 10 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wojciech Rogowski's work include Neuroendocrine Tumor Research Advances (6 papers), Neuroblastoma Research and Treatments (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Wojciech Rogowski is often cited by papers focused on Neuroendocrine Tumor Research Advances (6 papers), Neuroblastoma Research and Treatments (6 papers) and Colorectal Cancer Treatments and Studies (6 papers). Wojciech Rogowski collaborates with scholars based in Poland, United States and United Kingdom. Wojciech Rogowski's co-authors include Ewa Iżycka‐Świeszewska, Violetta Sulżyc‐Bielicka, Tomasz Sarosiek, Prasant Mohanty, Krzysztof Leśniewski-Kmak, John Simard, Thierry André, Mark Saunders, Ron N. Apte and Michael Stecher and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Wojciech Rogowski

32 papers receiving 637 citations

Peers

Countries citing papers authored by Wojciech Rogowski

Since Specialization

Citations

This map shows the geographic impact of Wojciech Rogowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wojciech Rogowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wojciech Rogowski more than expected).

Fields of papers citing papers by Wojciech Rogowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wojciech Rogowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wojciech Rogowski. The network helps show where Wojciech Rogowski may publish in the future.

Co-authorship network of co-authors of Wojciech Rogowski

This figure shows the co-authorship network connecting the top 25 collaborators of Wojciech Rogowski. A scholar is included among the top collaborators of Wojciech Rogowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wojciech Rogowski. Wojciech Rogowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bispecific innate cell engager (ICE) AFM24 in combination with atezolizumab in patients with advanced/metastatic EGFR -expressing non-small cell lung cancer (NSCLC) without driver mutations: Initial results from a phase 2a study. 2025 ·Journal of Clinical Oncology ·Hye Ryun Kim, (unknown), Juanita Lopez, Anthony B. El-Khoueiry, Omar Saavedra, Jacob Thomas, Wojciech Rogowski, Valentina Boni, Cezary Szczylik, Andrés Cervantes, Iwona Ługowska, Rodryg Ramlau, Eric S. Christenson, Byoung Yong Shim, Marina Chiara Garassino, Ulrike Gärtner, Daniel Schütz, (unknown), Michael Emig, Daniela Morales-Espinosa	0
2	Preliminary results from the phase 2 study of AFM24 in combination with atezolizumab in patients with EGFR wild-type (EGFR-WT) non-small cell lung cancer (NSCLC). 2024 ·Journal of Clinical Oncology ·Hye Ryun Kim, Omar Saavedra, Andrés Cervantes, Iwona Ługowska, (unknown), Anthony B. El-Khoueiry, Jacob Thomas, Wojciech Rogowski, Juanita Lopez, Byoung Yong Shim, Eric S. Christenson, Valentina Boni, Marina Chiara Garassino, Ramón Yarza, (unknown), (unknown), (unknown), (unknown), Michael Emig, (unknown)	9
3	I say a little prayer for my singlehood: exploring the role of prayer for single adults’ mental health 2024 ·Journal of Beliefs and Values ·Katarzyna Adamczyk, (unknown), Agnieszka E. Łyś, Wojciech Rogowski	1
4	Investigation of Neural Microenvironment in Prostate Cancer in Context of Neural Density, Perineural Invasion, and Neuroendocrine Profile of Tumors 2021 ·Frontiers in Oncology ·Dawid Sigorski, (unknown), Aleksandra Sejda, Wojciech Rogowski, Ewa Iżycka‐Świeszewska	24
5	Successful treatment of an enterovesical fistula due to Crohn’s disease with stem cell transplantation: a case report 2018 ·Gastroenterology Review ·(unknown), Anna Sarnowska, Wojciech Rogowski, Marek Durlik, (unknown), Grażyna Rydzewska	6
6	Colorectal cancer and Cryptosporidium spp. infection 2018 ·PLoS ONE ·Violetta Sulżyc‐Bielicka, Lidia Kołodziejczyk, (unknown), Dariusz Bielicki, Krzysztof Safranow, (unknown), Józef Kładny, Wojciech Rogowski	37
7	MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study 2017 ·The Lancet Oncology ·Tamas Hickish, Thierry André, Lucjan Wyrwicz, Mark Saunders, Tomasz Sarosiek, Judit Kocsis, Radim Němeček, Wojciech Rogowski, Krzysztof Leśniewski-Kmak, Luboš Petruželka, Ron N. Apte, Prasant Mohanty, Michael Stecher, John Simard, Aimery de Gramont	121
8	Retroperitoneal Ganglioneuroma Mimicking a Kidney Tumor. Case Report 2017 ·Polish Journal of Radiology ·(unknown), Wojciech Rogowski, Ryszard Pacho, (unknown), (unknown)	8
9	Congenital anomalies of the genitourinary system can help in diagnosis of the primary site of metastatic cancer: a case report and a review of the literature 2016 ·OncoTargets and Therapy ·Aleksandra Czerw, (unknown), Jerzy Walecki, Wojciech Rogowski, Andrzej Deptała, Anna Nasierowska‐Guttmejer	0
10	Optimal duration of a first-line palliative chemotherapy in disseminated colorectal cancer – a review of the literature from a developing country perspective 2016 ·Współczesna Onkologia ·Wojciech Rogowski, Violetta Sulżyc‐Bielicka	5
11	E2F1/TS Immunophenotype and Survival of Patients with Colorectal Cancer Treated with 5FU-Based Adjuvant Therapy 2016 ·Pathology & Oncology Research ·Violetta Sulżyc‐Bielicka, Paweł Domagała, Dariusz Bielicki, Krzysztof Safranow, Wojciech Rogowski, W Domagała	8
12	Prospective noninterventional study on the use of panitumumab monotherapy in patients with recurrent or progressive colorectal cancer: the VECTIS study 2015 ·Cancer Management and Research ·Radek Lakomý, Wojciech Rogowski, Béla Pikó, (unknown), (unknown), (unknown)	3
13	CA-SSR1 Polymorphism in Intron 1 of the EGFR Gene in Patients with Malignant Tumors Who Develop Acneiform Rash Associated with the Use of Cetuximab 2015 ·Molecular Diagnosis & Therapy ·(unknown), Monika Rucińska, Wojciech Rogowski, Marzena Anna Lewandowska, Jerzy Tujakowski, (unknown), Anna Kowalczyk, (unknown), Rafał Dziadziuszko, Sergiusz Nawrocki	7
14	Health resource utilization associated with skeletal-related events: results from a retrospective European study 2015 ·The European Journal of Health Economics ·Jean‐Jacques Body, João Pereira, H.P. Sleeboom, Nikos Maniadakis, Evangelos Terpos, Yves P. Acklin, Jindřich Fínek, Oliver Günther, Guy Hechmati, (unknown), Luís Costa, Wojciech Rogowski, Hareth Nahi, Roger von Moos	18
15	Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma 2014 ·American Journal of Therapeutics ·Małgorzata Sokołowska‐Wojdyło, Aleksandra G. Florek, Jan Maciej Zaucha, Ewa Chmielowska, Agnieszka Giza, Wanda Knopińska‐Posłuszny, (unknown), Witold Prejzner, Joanna Romejko‐Jarosińska, Ewa Paszkiewicz‐Kozik, (unknown), Jan Walewski, Wojciech Rogowski, Alina Grzanka, Waldemar Placek, (unknown), Anna Kowalczyk, Roman Nowicki, Wojciech Jurczak	9
16	A randomised, double-blind, placebo-controlled phase 2 study of trebananib (AMG 386) in combination with FOLFIRI in patients with previously treated metastatic colorectal carcinoma 2013 ·British Journal of Cancer ·Marc Peeters, A. H. Strickland, Mikhail Lichinitser, Amritha Suresh, G. Manikhas, Jeremy Shapiro, Wojciech Rogowski, Xin‐En Huang, Benjamin Wu, Douglas Warner, Rajul K. Jain, Niall C. Tebbutt	60
17	Efficacy and safety of ipilimumab therapy in patients with metastatic melanoma: a retrospective multicenter analysis 2013 ·Współczesna Onkologia ·(unknown), Tomasz Świtaj, Jacek Mackiewicz, Ewa Kalinka‐Warzocha, Marek Z. Wojtukiewicz, (unknown), Sławomir Falkowski, Wojciech Rogowski, Andrzej Maćkiewicz, Piotr Rutkowski	13
18	Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain 2012 ·Breast Cancer Research ·Renata Duchnowska, Rafał Dziadziuszko, Tomasz Trojanowski, Tomasz Mandat, Waldemar Och, Bogumiła Czartoryska-Arłukowicz, Barbara Radecka, Wojciech Olszewski, Franciszek Szubstarski, Wojciech Kozłowski, Bożena Jarosz, Wojciech Rogowski, Anna Kowalczyk, Janusz Limon, Wojciech Biernat, Jacek Jassem	77
19	Konkurencja na rynku usług bankowych - miary koncentracji 2001 ·Bank i Kredyt ·Wojciech Rogowski	5
20	Alianse strategiczne przedsiębiorstw w warunkach polskich 2000 ·Economics and Organization of Enterprise ·Maciej Gawinecki, Wiesław M. Grudzewski, Wojciech Rogowski	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact